109 related articles for article (PubMed ID: 3945665)
1. TFMPP may produce its stimulus effects via a 5-HT1B mechanism.
McKenney JD; Glennon RA
Pharmacol Biochem Behav; 1986 Jan; 24(1):43-7. PubMed ID: 3945665
[TBL] [Abstract][Full Text] [Related]
2. Stimulus generalization of 1-(3-trifluoromethylphenyl)piperazine (TFMPP) to propranolol, pindolol, and mesulergine.
Glennon RA; Pierson ME; McKenney JD
Pharmacol Biochem Behav; 1988 Jan; 29(1):197-9. PubMed ID: 2895480
[TBL] [Abstract][Full Text] [Related]
3. Mechanistic investigation of the stimulus properties of 1-(3-trifluoromethylphenyl)piperazine.
Herndon JL; Pierson ME; Glennon RA
Pharmacol Biochem Behav; 1992 Nov; 43(3):739-48. PubMed ID: 1333084
[TBL] [Abstract][Full Text] [Related]
4. Discriminative stimulus properties of the serotonin agonist 1-(3-trifluoromethylphenyl)piperazine (TFMPP).
Glennon RA; McKenney JD; Young R
Life Sci; 1984 Oct; 35(14):1475-80. PubMed ID: 6482668
[TBL] [Abstract][Full Text] [Related]
5. Site-selective serotonin agonists as discriminative stimuli.
Glennon RA
Psychopharmacol Ser; 1988; 4():15-31. PubMed ID: 3293039
[TBL] [Abstract][Full Text] [Related]
6. Discriminative stimulus properties of eltoprazine in the pigeon.
Olivier B; Herremans A; Mos J; van Drimmelen M; Tulp M; van Oorschot R; Hijzen T
Pharmacol Biochem Behav; 1999 Oct; 64(2):421-7. PubMed ID: 10515324
[TBL] [Abstract][Full Text] [Related]
7. Involvement of 5-HT2C receptors in mediating the discriminative stimulus properties of m-chlorophenylpiperazine (mCPP).
Callahan PM; Cunningham KA
Eur J Pharmacol; 1994 May; 257(1-2):27-38. PubMed ID: 8082704
[TBL] [Abstract][Full Text] [Related]
8. Use of TFMPP stimulus properties as a model of 5-HT1B receptor activation.
Schechter MD
Pharmacol Biochem Behav; 1988 Sep; 31(1):53-7. PubMed ID: 3252260
[TBL] [Abstract][Full Text] [Related]
9. 5-HT1 and 5-HT2 binding characteristics of some quipazine analogues.
Glennon RA; Slusher RM; Lyon RA; Titeler M; McKenney JD
J Med Chem; 1986 Nov; 29(11):2375-80. PubMed ID: 3783595
[TBL] [Abstract][Full Text] [Related]
10. Discriminative stimulus properties of mCPP: evidence for a 5-HT2C receptor mode of action.
Gommans J; Hijzen TH; Maes RA; Olivier B
Psychopharmacology (Berl); 1998 Jun; 137(3):292-302. PubMed ID: 9683007
[TBL] [Abstract][Full Text] [Related]
11. Effects of repeated administration of the monoamine oxidase inhibitor phenelzine on the discriminability of d-lysergic acid diethylamide (LSD) and 1-(m-trifluoromethylphenyl) piperazine (TFMPP).
Cunningham KA; Carroll BA; Appel JB
Psychopharmacology (Berl); 1986; 89(1):134-5. PubMed ID: 3090587
[TBL] [Abstract][Full Text] [Related]
12. Discriminative stimulus properties of the serotonergic compound eltoprazine.
Ybema CE; Slangen JL; Olivier B; Mos J
J Pharmacol Exp Ther; 1992 Mar; 260(3):1045-51. PubMed ID: 1532031
[TBL] [Abstract][Full Text] [Related]
13. Discriminative stimulus properties of the 5-HT1A agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH DPAT).
Glennon RA
Pharmacol Biochem Behav; 1986 Jul; 25(1):135-9. PubMed ID: 2944129
[TBL] [Abstract][Full Text] [Related]
14. Discriminative stimulus properties of flesinoxan.
Ybema CE; Slangen JL; Olivier B; Mos J
Pharmacol Biochem Behav; 1990 Apr; 35(4):781-4. PubMed ID: 2140607
[TBL] [Abstract][Full Text] [Related]
15. Mechanistic studies on DOM as a discriminative stimulus.
Glennon RA; Hauck AE
Pharmacol Biochem Behav; 1985 Dec; 23(6):937-41. PubMed ID: 2934750
[TBL] [Abstract][Full Text] [Related]
16. Discriminative stimulus properties of the serotonergic agent 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI).
Glennon RA
Life Sci; 1986 Sep; 39(9):825-30. PubMed ID: 2943960
[TBL] [Abstract][Full Text] [Related]
17. Agonist action at 5-HT1C receptors facilitates 5-HT1A receptor-mediated spontaneous tail-flicks in the rat.
Bervoets K; Millan MJ; Colpaert FC
Eur J Pharmacol; 1990 Nov; 191(2):185-95. PubMed ID: 2150818
[TBL] [Abstract][Full Text] [Related]
18. Possible 5-hydroxytryptamine1 (5-HT1) receptor involvement in the stimulus properties of 1-(m-trifluoromethylphenyl)piperazine (TFMPP).
Cunningham KA; Appel JB
J Pharmacol Exp Ther; 1986 May; 237(2):369-77. PubMed ID: 2939233
[TBL] [Abstract][Full Text] [Related]
19. Antagonism of the effects of the hallucinogen DOM and the purported 5-HT agonist quipazine by 5-HT2 antagonists.
Glennon RA; Young R; Rosecrans JA
Eur J Pharmacol; 1983 Jul; 91(2-3):189-96. PubMed ID: 6617740
[TBL] [Abstract][Full Text] [Related]
20. Discriminative stimulus properties of m-chlorophenylpiperazine.
Winter JC; Rabin RA
Pharmacol Biochem Behav; 1993 May; 45(1):221-3. PubMed ID: 8516361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
